INTRODUCTION
Colorectal cancer is a major public health issue in all industrialized countries. Screening using guaiac fecal occult blood tests (G-FOBT) reduces specific mortality related to colorectal cancer (1) . Several studies have concluded that both the Magstream (Fujirebio, Japan) and OC-Sensor (Eiken Chemical Co, Japan) automated immunochemical (I-) FOBTs offer a gain in sensitivity in the detection of advanced neoplasias, compared to G-FOBT, at a cost of lower specificity (2) (3) (4) . For both tests, ideal balance between sensitivity and specificity can be reached by variation in hemoglobin (Hb) concentration cut-off and number of samples (5-8).
For both tests, a gain in both sensitivity and specificity for the detection of advanced neoplasias was possible (4, (7) (8) .
Since it has been established that I-FOBTs perform better than G-FOBTs, these tests are expected to be used in all national screening programs using FOBT. Accordingly, the use of a fecal immunochemical test has been included in US guidelines for colorectal cancer screening (9) . However, several I-FOBT are available and their performance is difficult to compare since the cut-off provided in studies is expressed in concentration of hemoglobin in the collecting tube depending on the concentration of hemoglobin in the feces, but also on the volume of buffer in the tube, and on the amount of feces introduced in the tube. Therefore, optimal test, optimal number of samples, or optimal hemoglobin concentration cut-off are for the moment indeterminate (10) . Moreover seasonal variations in positivity rates of screening programs using OC Sensor or Magstream I-FOBT has raised the question of the sensibility to temperature (11) (12) (13) , and laboratory analyses have established a decrease in hemoglobin concentration in OC Sensor I-FOBT with increasing delay in the sample (11, 14) .
As a summary, the performance of I-FOBT depends mainly on the test's sensitivity to hemoglobin, on its reproducibility of sampling and measurement, and on the stability of 4 hemoglobin in the collecting tube, in particular with regard to temperature variations and delay from fecal sampling to test analysis.
Our study aimed to compare measurement precision and reproducibility, together with hemoglobin measurement stability at varying storage temperatures and varying delays between sampling and analysis of three I-FOBTs previously used in colorectal cancer screening programs: Magstream (New Hemtube) analyzed using a Magstream HT automated instrument (Fujirebio, Japan), OC-Sensor (OC-Auto sampling bottle3) analyzed using an OCSensor Diana instrument (Eiken Chemical Co, Japan; distributed by Mast Diagnosis), and FOB Gold (distributed by SKD, France) analyzed using a SENTiFOB instrument (Sentinel diagnostics, Italy).
MATERIAL AND METHODS

Immunochemical fecal occult blood tests
All three tests use polyclonal rabbit antibodies directed against human hemoglobin HbA. All tests are fully automated (Table 1) . Analysis of OC-Sensor and FOB Gold is based on immunoturbidimetry, which involves a measurement of the absorbance of light through the tube, which increases with the importance of hemoglobin-antibodies complexes. Analysis of Magstream involves the use of an automated visual measurement of migration of agglutinated magnetic particles. In routine use, the crude pixel value generated by Magstream is converted into MSR units, an arbitrary unit proposed by the manufacturer. For the present study, we asked Fujirebio to provide software (not routinely integrated in the machine) to allow for the collection of the measurements (pixel values 
Fecal sampling method
Firstly, freshly collected stools, obtained from ten healthy subjects aged less than 50 years, were tested using all three tests to confirm the initial absence of hemoglobin. These stools were mixed and homogenized, then divided into containers. In each of these containers, a volume of human whole blood lysate, the hemoglobin content of which had previously been measured (Advia 2120, Siemens), was added to obtain all pre-specified hemoglobin concentrations in the stool. Each container was vigorously shaken after adjunction of blood.
For each of the concentrations, sampling of all three tests was performed using the same containers, ensuring that concentration was identical for all tests. Finally collecting tubes were shaken after sampling, and before analysis. This procedure was repeated two times leading to two distinct stool mixtures, one being analyzed to evaluate reproducibility, the other to evaluate stability to storage.
Experimental plan
Two distinct experiments were performed: the first one to evaluate and compare reproducibility of the tests (experiment 1), the other one to evaluate and compare their sensitivity to temperature and delay of storage (experiment 2). For each of these two experiments, a distinct stool mixture was performed, as described above.
Experiment 1(stool mixture n°1)
In order to compare tests for a given hemoglobin concentration, we initially explored, for each test, the relationship between concentration in the feces and the value provided by the instrument, for a total of ten values of hemoglobin concentration in feces, varying from 0 to 350ȝg Hb/g of feces. This range of concentrations was selected to: 1/ cover the range of usual or proposed hemoglobin positivity cut-offs of all tests, and 2/ cover the range of physiological bleeding of colorectal lesions (15). To assess measurement reproducibility, ten tubes were 6 collected for each instrument and for each concentration, and all tubes were repeatedly analyzed five times leading to a total of fifty readings per concentration and test. In this experiment, all prepared I-FOBTs were stored for 3 days at 10°C before being analyzed, approximating to the conditions of a screening program involving mailed samples.
Experiment 2 (stool mixture n°2)
A second experimental plan was developed to assess the influence of storage temperature and 
Statistical analysis
Reproducibility of I-FOBTs (Experiment 1)
For each test, and for each of the experimental concentrations, the inter-tube and intra-tube variances were determined using a random effect model (SAS proc mixed). This procedure enabled us to compute the variation coefficients due to sampling (inter-tube) and reading (intra-tube).
Stability to temperature and duration of storage (Experiment 2)
In an exploratory analysis we computed the mean measurement obtained for each test, according to temperature, concentration or delay (Table 2) was observed between concentrations in the entire range of these tested concentrations.
Reproducibility (Figure 2)
Reproducibility could be explored in the entire concentration range for OC-Sensor and FOB Gold. However it was only explored for concentrations below 250ȝg Hb/g of feces for
Magtream, since for higher concentrations, the absence of measurement variation between concentrations using this test would lead to artificially good reproducibility.
The best reproducibility (smaller total variation coefficient) was observed with OC-Sensor, 
reproducibility was observed with the FOB Gold test. Indeed, the mean total variation coefficient observed between 75 and 250ȝg Hb/g of feces was 0.07 for OC-Sensor, 0.10 for Magstream and 0.18 for FOB Gold.
For all tests, measurement variability involved inter-tube variability, rather than intra-tube variability (the variation coefficients associated with sampling were far greater than those associated with reading). Intra-tube variability was low for all tests (the mean coefficient of variation due to reading between 75 and 250ȝg Hb /g of feces was 0.025, 0.016 and 0.060 for FOB Gold, OC-Sensor and Magstream respectively).
The difference between these sources of variation was the highest for FOB Gold, for which the inter-tube variability was particularly important compared to the other tests. The mean coefficient of variation due to sampling between 75 and 250ȝg Hb/g of feces was 0.15 for FOB Gold, whereas it was only 0.10 for OC-Sensor and 0.07 for Magstream.
Inter-tube variability associated with FOB gold tended to decrease as the hemoglobin concentration in feces increased. Inter-tube variability associated with OC-Sensor was stable between 75 and 250ȝg Hb/g of feces, but was high for concentrations below 75, or above 250ȝg Hb/g of feces. The latter concentrations were higher than the upper limits of good performance recommended by the manufacturer. Inter-tube variability using Magstream increased as did fecal hemoglobin concentration up to 150ȝg Hb/g of feces, then decreased, due to a non-linear relationship between pixels and concentration.
Experiment 2 Stability
Mean measurements according to test, temperature, concentration and time are provided in Table 2 . For all three tests, measurement was stable over time, independently of storage At 30°C, the performance of OC-Sensor was far better than that of FOB Gold and Magstream.
Indeed, the mean daily decrease in measurement observed with OC-Sensor was 8.6% (p<10 -3 ), whereas the mean decrease in measurement observed on the first day was 30% for experiment should be similar to that which occurs in real screening settings, since it is solely an effect of the automated analyzer itself.
The lower inter-tube variability when using OC-Sensor could be explained by a more accurately calibrated quantity of stool incorporated in the sample (not measurable in our study). In addition more overlap occurred between the evaluated concentrations with FOB Gold and Magstream than with OC Sensor. Accordingly the loss in precision of these tests (including inter-tube and intra-tube variability) could have consequences on positivity rates in real screening settings.
Temperature-related hemoglobin degradation is expected; however, it can be delayed by the use of a suitable stabilizing agent in the buffer. Such stabilizing agents are included in all three tests. Nevertheless, the stability of hemoglobin measurement at varying temperatures and over time was better with OC Sensor than with Magstream and far better than FOB Gold.
The superiority of OC Sensor was also observed in the NHS Evaluation report (16). At a temperature of 20°C, the decrease observed with FOB Gold and Magstream was at least twice that observed with OC-Sensor. At 30°C, the performance of Magstream and FOB Gold was very poor, whereas the OC Sensor was much better and remained reliable, even at this high temperature. I-FOBT sensitivity variations related to storage duration have previously been described in both laboratory experiments and genuine screening settings (11) (12) (13) (14) . The interaction between storage duration and temperature has been quantified for the OC Sensor test in a laboratory experiment: the daily decrease in fecal hemoglobin measurement was 0.3% at 4°C, 2.2% at 20°C and 3.7% at 28°C (14) . Our findings (2% daily decrease at 20°C and 9% daily decrease at 30°C) are consistent with this observation, although the decrease observed at 30°C appeared more important. This could be explained by a difference in initial hemoglobin concentration in feces, the relative decrease being higher for small initial concentrations. Such differences in sensitivity related to storage temperature and duration, However, the fact that this study was entirely laboratory-performed enabled every parameter to be controlled, as from the introduction of blood into the stool. This is not the case for studies exploring the stability of fecal samples sent to the laboratory after having been performed by the patient at home, measurement of initial hemoglobin concentration in the stool, and storage duration or temperature from home to laboratory being unknown (11, 14) .
This also enabled the three tests to be compared on the same stools. Moreover, the use of blood lysate guaranteed the best possible conditions for the antibody-antigen reaction. Finally, -18) . Costs of the tests should also be considered, together with adaptation of screening programs to limit the effect of sensitivity of tests to temperature on their performances (12) . Further studies and cost-effectiveness analysis are needed to compare Magstream and OC Sensor in real screening settings, appropriately taking into account temperature and duration of storage.
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